Evaluating the spike in the symptomatic proportion of SARS-CoV-2 in China in 2022 with variolation effects: a modeling analysis

Despite most COVID-19 infections being asymptomatic, mainland China had a high increase in symptomatic cases at the end of 2022. In this study, we examine China's sudden COVID-19 symptomatic surge using a conceptual SIR-based model. Our model considers the epidemiological characteristics of SAR...

Full description

Bibliographic Details
Main Authors: Salihu S. Musa, Shi Zhao, Ismail Abdulrashid, Sania Qureshi, Andrés Colubri, Daihai He
Format: Article
Language:English
Published: KeAi Communications Co., Ltd. 2024-06-01
Series:Infectious Disease Modelling
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2468042724000319
_version_ 1827287960328863744
author Salihu S. Musa
Shi Zhao
Ismail Abdulrashid
Sania Qureshi
Andrés Colubri
Daihai He
author_facet Salihu S. Musa
Shi Zhao
Ismail Abdulrashid
Sania Qureshi
Andrés Colubri
Daihai He
author_sort Salihu S. Musa
collection DOAJ
description Despite most COVID-19 infections being asymptomatic, mainland China had a high increase in symptomatic cases at the end of 2022. In this study, we examine China's sudden COVID-19 symptomatic surge using a conceptual SIR-based model. Our model considers the epidemiological characteristics of SARS-CoV-2, particularly variolation, from non-pharmaceutical intervention (facial masking and social distance), demography, and disease mortality in mainland China. The increase in symptomatic proportions in China may be attributable to (1) higher sensitivity and vulnerability during winter and (2) enhanced viral inhalation due to spikes in SARS-CoV-2 infections (high transmissibility). These two reasons could explain China's high symptomatic proportion of COVID-19 in December 2022. Our study, therefore, can serve as a decision-support tool to enhance SARS-CoV-2 prevention and control efforts. Thus, we highlight that facemask-induced variolation could potentially reduces transmissibility rather than severity in infected individuals. However, further investigation is required to understand the variolation effect on disease severity.
first_indexed 2024-04-24T11:20:55Z
format Article
id doaj.art-d8ed57188965401988b0e1d894f101f8
institution Directory Open Access Journal
issn 2468-0427
language English
last_indexed 2024-04-24T11:20:55Z
publishDate 2024-06-01
publisher KeAi Communications Co., Ltd.
record_format Article
series Infectious Disease Modelling
spelling doaj.art-d8ed57188965401988b0e1d894f101f82024-04-11T04:41:44ZengKeAi Communications Co., Ltd.Infectious Disease Modelling2468-04272024-06-0192601617Evaluating the spike in the symptomatic proportion of SARS-CoV-2 in China in 2022 with variolation effects: a modeling analysisSalihu S. Musa0Shi Zhao1Ismail Abdulrashid2Sania Qureshi3Andrés Colubri4Daihai He5Department of Genomics and Computational Biology, University of Massachusetts Chan Medical School, Worcester, MA, 01605, USA; Department of Applied Mathematics, Hong Kong Polytechnic University, Hong Kong SAR, China; Department of Mathematics, Aliko Dangote University of Science and Technology, Kano, NigeriaSchool of Public Health, Tianjin Medical University, Tianjin, 300070, ChinaSchool of Finance and Operations Management, The University of Tulsa, 800 South Tucker Dr., Tulsa, OK, 74104, USADepartment of Basic Sciences and Related Studies, Mehran University of Engineering and Tech., Jamshoro, Pakistan; Department of Computer Science and Mathematics, Lebanese American University, Beirut, LebanonDepartment of Genomics and Computational Biology, University of Massachusetts Chan Medical School, Worcester, MA, 01605, USA; Corresponding author. Department of Genomics and Computational Biology, University of Massachusetts, Medical School, MA, 01605, USA.Department of Applied Mathematics, Hong Kong Polytechnic University, Hong Kong SAR, China; Corresponding author. Department of Applied Mathematics, Hong Kong Polytechnic University, Hong Kong Special Administrative Region of China.Despite most COVID-19 infections being asymptomatic, mainland China had a high increase in symptomatic cases at the end of 2022. In this study, we examine China's sudden COVID-19 symptomatic surge using a conceptual SIR-based model. Our model considers the epidemiological characteristics of SARS-CoV-2, particularly variolation, from non-pharmaceutical intervention (facial masking and social distance), demography, and disease mortality in mainland China. The increase in symptomatic proportions in China may be attributable to (1) higher sensitivity and vulnerability during winter and (2) enhanced viral inhalation due to spikes in SARS-CoV-2 infections (high transmissibility). These two reasons could explain China's high symptomatic proportion of COVID-19 in December 2022. Our study, therefore, can serve as a decision-support tool to enhance SARS-CoV-2 prevention and control efforts. Thus, we highlight that facemask-induced variolation could potentially reduces transmissibility rather than severity in infected individuals. However, further investigation is required to understand the variolation effect on disease severity.http://www.sciencedirect.com/science/article/pii/S2468042724000319SARS-CoV-2EpidemicEpidemiological modelingReproduction numberVariolation
spellingShingle Salihu S. Musa
Shi Zhao
Ismail Abdulrashid
Sania Qureshi
Andrés Colubri
Daihai He
Evaluating the spike in the symptomatic proportion of SARS-CoV-2 in China in 2022 with variolation effects: a modeling analysis
Infectious Disease Modelling
SARS-CoV-2
Epidemic
Epidemiological modeling
Reproduction number
Variolation
title Evaluating the spike in the symptomatic proportion of SARS-CoV-2 in China in 2022 with variolation effects: a modeling analysis
title_full Evaluating the spike in the symptomatic proportion of SARS-CoV-2 in China in 2022 with variolation effects: a modeling analysis
title_fullStr Evaluating the spike in the symptomatic proportion of SARS-CoV-2 in China in 2022 with variolation effects: a modeling analysis
title_full_unstemmed Evaluating the spike in the symptomatic proportion of SARS-CoV-2 in China in 2022 with variolation effects: a modeling analysis
title_short Evaluating the spike in the symptomatic proportion of SARS-CoV-2 in China in 2022 with variolation effects: a modeling analysis
title_sort evaluating the spike in the symptomatic proportion of sars cov 2 in china in 2022 with variolation effects a modeling analysis
topic SARS-CoV-2
Epidemic
Epidemiological modeling
Reproduction number
Variolation
url http://www.sciencedirect.com/science/article/pii/S2468042724000319
work_keys_str_mv AT salihusmusa evaluatingthespikeinthesymptomaticproportionofsarscov2inchinain2022withvariolationeffectsamodelinganalysis
AT shizhao evaluatingthespikeinthesymptomaticproportionofsarscov2inchinain2022withvariolationeffectsamodelinganalysis
AT ismailabdulrashid evaluatingthespikeinthesymptomaticproportionofsarscov2inchinain2022withvariolationeffectsamodelinganalysis
AT saniaqureshi evaluatingthespikeinthesymptomaticproportionofsarscov2inchinain2022withvariolationeffectsamodelinganalysis
AT andrescolubri evaluatingthespikeinthesymptomaticproportionofsarscov2inchinain2022withvariolationeffectsamodelinganalysis
AT daihaihe evaluatingthespikeinthesymptomaticproportionofsarscov2inchinain2022withvariolationeffectsamodelinganalysis